Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
about
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open QuestionsMesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesThe potential of polymeric micelles in the context of glioblastoma therapy.Ultrasound exposure improves the targeted therapy effects of galactosylated docetaxel nanoparticles on hepatocellular carcinoma xenograftsCurrent status of gene therapy for brain tumors.Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction.Oncolytic adenoviruses: A thorny path to glioma cureBiosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoterFluorescent protein-expressing neural progenitor cells as a tool for transplantation studies.Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.Creating anatomically accurate and reproducible intracranial xenografts of human brain tumorsMMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells.Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer.A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastomaN-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapyGlioma virus therapies between bench and bedside.Therapeutic cell carriers: a potential road to cure glioma.Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?Cells as delivery vehicles for cancer therapeutics.Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?Antitumor Activity of Rat Mesenchymal Stem Cells during Direct or Indirect Co-Culturing with C6 Glioma Cells.Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy.Functionally Active Gap Junctions between Connexin 43-Positive Mesenchymal Stem Cells and Glioma Cells.Neural stem cell-mediated delivery of oncolytic adenovirus.Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.Monitoring adenoviral based gene delivery in rat glioma by molecular imaging.Oncolytic virotherapy for gliomas: steps toward the future.VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model.Stem cells in cancer therapy: opportunities and challenges.Concise Review: Neural Stem Cell-Mediated Targeted Cancer Therapies
P2860
Q26775038-1BA0C38B-5A0F-40FB-8FD2-EBAFDB7C168EQ26799013-9DBF68B1-EDA9-4F3B-A0CF-CEE04CF1F443Q27693205-16473AD4-4CED-46CF-81A9-1B115BB88740Q28487464-3CFB8A51-0A0B-4A41-B4A1-FFB02A902DB9Q34318157-77A7E56C-872A-4385-B051-B329B2C810A7Q34943738-DD7315FB-3705-4ED0-A259-CE224ABC43BEQ35077747-D7262DEE-EE9A-4D23-820F-F8F0BF2DC623Q35184239-047E2058-FBFA-4006-B0EB-2712AACF89B6Q35188823-B0A97A36-4E3A-4EF8-BEE7-DA08BC6931B0Q36083446-7D5F597E-B574-49E5-8BB7-A10B7E69CA33Q36412837-F425A487-AB22-4690-B561-5C27D145FA0FQ36421256-1D1A24E7-DA47-47EF-B967-1B9D4A1B2B55Q36597119-88AD310E-079B-49D1-BF8A-977B5ACB4A21Q36976226-B2E35578-C156-476E-8341-C25C2AC27D63Q37124552-1205CDDD-A111-40C6-A998-354F8026C8ABQ37316856-3B44AAF2-E66C-4FB8-BFEC-1470B7522D32Q37580510-CFE71E40-AD27-4D9A-9C24-28CEDECF487EQ38213836-B49A0B68-02D8-4D91-8A99-8FEB24A59B8FQ38218674-B592F8A4-7F8E-4A1C-A271-8D562BD9F851Q38226664-6E902615-3DA7-44B1-A661-40EF806EAACEQ38227489-756C2CFF-0817-49FB-88C1-49D7B1FFB17BQ38348844-E338FC77-D80E-4C6F-A6FE-AC911D46A595Q38791939-31B98504-BEE9-4325-BC98-ED788FA05C80Q38828208-2F37EB01-F5DC-4E20-BA8F-2159BAF066F2Q38868552-927A1B6A-6E0C-4A6F-8506-68D40CF6A439Q39023173-672C62C9-B3E8-4F40-BB43-2C4084B57D1AQ39198277-4E560745-C35C-4300-8F8A-C74B00E3DC3BQ40585840-B28F7635-4785-4330-B8C9-5F43DAD6510EQ43436260-DF2EB8CF-3CDD-4AEC-8873-8AFDD84CD695Q44796764-004E4806-C31B-45C3-950E-A5E50CE6619EQ46295328-1611E922-6FD7-4189-932E-D003B5C38760Q47142453-774461C6-556F-4334-BAE5-894D6045BF36Q58724855-06226A4B-5AD7-4E1D-B242-3D8279F49E2B
P2860
Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pharmacokinetic study of neura ...... orthotopic brain tumor model.
@ast
Pharmacokinetic study of neura ...... orthotopic brain tumor model.
@en
type
label
Pharmacokinetic study of neura ...... orthotopic brain tumor model.
@ast
Pharmacokinetic study of neura ...... orthotopic brain tumor model.
@en
prefLabel
Pharmacokinetic study of neura ...... orthotopic brain tumor model.
@ast
Pharmacokinetic study of neura ...... orthotopic brain tumor model.
@en
P2093
P2860
P356
P1433
P1476
Pharmacokinetic study of neura ...... orthotopic brain tumor model.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2012.21
P50
P577
2012-05-04T00:00:00Z